SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q4 2013 13F Holders as of 31 Dec 2013
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 12,473,872
- Share change
- -15,140
- Total reported value
- $76,374,256
- Put/Call ratio
- 151%
- Price per share
- $6.12
- Number of holders
- 40
- Value change
- -$92,057
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
23,860
|
$143,000 | — | 30 Sep 2013 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
14,300
|
$86,000 | — | 30 Sep 2013 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
750
|
$4,000 | — | 30 Sep 2013 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2013
As of 31 Dec 2013,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,473,872 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, FIL Ltd, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, BlackRock Fund Advisors, Pine River Capital Management L.P., PICTET ASSET MANAGEMENT LTD, and Invesco Ltd..
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2013 vs Q3 2013 Across Filers
Q3 2013 holders
3
Q4 2013 holders
40
Holder diff
37
| Investor | Q3 2013 Shares | Q4 2013 Shares | Share Diff | Share Chg % | Q3 2013 Value $ | Q4 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.